Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phosphorylation-Dependent Feedback Inhibition of RIG-I by DAPK1 Identified by Kinome-wide siRNA Screening.
Willemsen J, Wicht O, Wolanski JC, Baur N, Bastian S, Haas DA, Matula P, Knapp B, Meyniel-Schicklin L, Wang C, Bartenschlager R, Lohmann V, Rohr K, Erfle H, Kaderali L, Marcotrigiano J, Pichlmair A, Binder M. Willemsen J, et al. Among authors: bastian s. Mol Cell. 2017 Feb 2;65(3):403-415.e8. doi: 10.1016/j.molcel.2016.12.021. Epub 2017 Jan 26. Mol Cell. 2017. PMID: 28132841 Free article.
Inter-annual trends of ultrafine particles in urban Europe.
Garcia-Marlès M, Lara R, Reche C, Pérez N, Tobías A, Savadkoohi M, Beddows D, Salma I, Vörösmarty M, Weidinger T, Hueglin C, Mihalopoulos N, Grivas G, Kalkavouras P, Ondráček J, Zíková N, Niemi JV, Manninen HE, Green DC, Tremper AH, Norman M, Vratolis S, Eleftheriadis K, Gómez-Moreno FJ, Alonso-Blanco E, Wiedensohler A, Weinhold K, Merkel M, Bastian S, Hoffmann B, Altug H, Petit JE, Favez O, Dos Santos SM, Putaud JP, Dinoi A, Contini D, Timonen H, Lampilahti J, Petäjä T, Pandolfi M, Hopke PK, Harrison RM, Alastuey A, Querol X. Garcia-Marlès M, et al. Among authors: bastian s. Environ Int. 2024 Mar;185:108510. doi: 10.1016/j.envint.2024.108510. Epub 2024 Feb 17. Environ Int. 2024. PMID: 38460241 Free article.
Recommendations for reporting equivalent black carbon (eBC) mass concentrations based on long-term pan-European in-situ observations.
Savadkoohi M, Pandolfi M, Favez O, Putaud JP, Eleftheriadis K, Fiebig M, Hopke PK, Laj P, Wiedensohler A, Alados-Arboledas L, Bastian S, Chazeau B, María ÁC, Colombi C, Costabile F, Green DC, Hueglin C, Liakakou E, Luoma K, Listrani S, Mihalopoulos N, Marchand N, Močnik G, Niemi JV, Ondráček J, Petit JE, Rattigan OV, Reche C, Timonen H, Titos G, Tremper AH, Vratolis S, Vodička P, Funes EY, Zíková N, Harrison RM, Petäjä T, Alastuey A, Querol X. Savadkoohi M, et al. Among authors: bastian s. Environ Int. 2024 Mar;185:108553. doi: 10.1016/j.envint.2024.108553. Epub 2024 Mar 2. Environ Int. 2024. PMID: 38460240 Free article.
TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16).
Colombo I, Koster KL, Holer L, Haefliger S, Rabaglio M, Bastian S, Schwitter M, Eckhardt K, Hayoz S, Mc Laughlin AM, Kloft C, Klose M, Halbherr S, Baumgartner C, Sessa C, Stathis A, Hess D, Joerger M. Colombo I, et al. Among authors: bastian s. Eur J Cancer. 2024 Apr;201:113588. doi: 10.1016/j.ejca.2024.113588. Epub 2024 Feb 2. Eur J Cancer. 2024. PMID: 38377773 Free article. Clinical Trial.
First-line durvalumab in patients with PD-L1 positive, advanced non-small cell lung cancer (NSCLC) with a performance status of 2 (PS2). Primary analysis of the multicenter, single-arm phase II trial SAKK 19/17.
Mark M, Froesch P, Gysel K, Rothschild SI, Addeo A, Ackermann CJ, Chiquet S, Schneider M, Ribi K, Maranta AF, Bastian S, von Moos R, Joerger M, Früh M; Swiss Group for Clinical Cancer Research (SAKK). Mark M, et al. Among authors: bastian s. Eur J Cancer. 2024 Mar;200:113600. doi: 10.1016/j.ejca.2024.113600. Epub 2024 Feb 5. Eur J Cancer. 2024. PMID: 38330766 Free article. Clinical Trial.
Residential Wood Combustion in Germany: A Twin-Site Study of Local Village Contributions to Particulate Pollutants and Their Potential Health Effects.
van Pinxteren D, Engelhardt V, Mothes F, Poulain L, Fomba KW, Spindler G, Cuesta-Mosquera A, Tuch T, Müller T, Wiedensohler A, Löschau G, Bastian S, Herrmann H. van Pinxteren D, et al. Among authors: bastian s. ACS Environ Au. 2023 Nov 22;4(1):12-30. doi: 10.1021/acsenvironau.3c00035. eCollection 2024 Jan 17. ACS Environ Au. 2023. PMID: 38250341 Free PMC article.
Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study.
Drew Y, Kim JW, Penson RT, O'Malley DM, Parkinson C, Roxburgh P, Plummer R, Im SA, Imbimbo M, Ferguson M, Rosengarten O, Steeghs N, Kim MH, Gal-Yam E, Tsoref D, Kim JH, You B, De Jonge M, Lalisang R, Gort E, Bastian S, Meyer K, Feeney L, Baker N, Ah-See ML, Domchek SM, Banerjee S; MEDIOLA Investigators. Drew Y, et al. Among authors: bastian s. Clin Cancer Res. 2024 Jan 5;30(1):50-62. doi: 10.1158/1078-0432.CCR-23-2249. Clin Cancer Res. 2024. PMID: 37939124 Free PMC article. Clinical Trial.
Cefoxitin versus carbapenems as definitive treatment for extended-spectrum β-lactamase-producing Klebsiella pneumoniae bacteremia in intensive care unit: a propensity-matched retrospective analysis.
Dequidt T, Bastian S, Nacher M, Breurec S, Carles M, Thiery G, Camous L, Tressieres B, Valette M, Pommier JD. Dequidt T, et al. Among authors: bastian s. Crit Care. 2023 Nov 1;27(1):418. doi: 10.1186/s13054-023-04712-2. Crit Care. 2023. PMID: 37915017 Free PMC article.
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial.
Rha SY, Oh DY, Yañez P, Bai Y, Ryu MH, Lee J, Rivera F, Alves GV, Garrido M, Shiu KK, Fernández MG, Li J, Lowery MA, Çil T, Cruz FM, Qin S, Luo S, Pan H, Wainberg ZA, Yin L, Bordia S, Bhagia P, Wyrwicz LS; KEYNOTE-859 investigators. Rha SY, et al. Lancet Oncol. 2023 Nov;24(11):1181-1195. doi: 10.1016/S1470-2045(23)00515-6. Epub 2023 Oct 21. Lancet Oncol. 2023. PMID: 37875143 Clinical Trial.
151 results